Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand
View Session Discussion + Q&A

Adult ID

Pediatric ID

Transplant
Session Type: Premeeting Workshop

PW08 - Infectious Disease Clinical Bootcamp for APPs ($)

Sunday, October 19, 2025
8:00 AM - 12:00 PM US ET
Location: B211-B212

Live Streamed On Demand
CME Credits: Maximum of 4 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 4 hours of MOC Credit
CNE Credits: Maximum of 4 hours of ANCC Credit
ACPE Credits: ACPE 0 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 4 of PACE contact hours
CE Broker: Maximum of 4 CE broker credit hours
Disclosure(s):
Leah H. Yoke, PA-C, MCHS: No financial relationships to disclose.
Courtney Russ-Friedman, MSN, FNP-BC: No financial relationships to disclose.
Paul S. Pottinger, MD: No financial relationships to disclose.
Christopher Ohl, MD: No financial relationships to disclose.
Denise McCulloch, MD, MPH: Pfizer, Inc.: Grant/Research Support
Daniel J. Morgan, MD, MS: No financial relationships to disclose.
John C. Williamson, PharmD: F2G Ltd: Grant/Research Support; Locus Biosciences: Grant/Research Support; ST Pharm: Grant/Research Support
Tresa Zielinski, DNP, RN, APRN-NP, CPNP-PC: No financial relationships to disclose.

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • describe new age parameters for prescribing antibiotic duration for at least 3 common pediatric illnesses;
  • identify the classic kawasaki disease patient;
  • describe the clinical implications of recent major clinical trials that are shaping current infectious disease practices;
  • discuss the place in therapy for dual beta-lactam regimens and novel beta-lactam/beta-lactamase inhibitor combinations, incorporating pathogen resistance mechanisms and pharmacokinetic/pharmacodynamic principles;
  • classify the varied risks of infection in immunosuppressed patients and common approaches to prophylaxis;
  • examine patients with fungal, bacterial, and viral infections and devise a treatment plan;
  • explain diagnostic stewardship and evaluate its impact on minimizing medical overuse and enhancing diagnostic accuracy;
  • identify strategies for the effective implementation of diagnostic tests to optimize patient care.

Presentations:

  • 8:00 AM - 8:10 AM US ET
    Introductory Remarks 

    Workshop Speaker: Leah H. Yoke, PA-C, MCHS – University of Washington; Fred Hutch Cancer Research Center

    Workshop Speaker: Courtney Russ-Friedman, MSN, FNP-BC – Atrium Health Wake Forest Baptist

  • 8:10 AM - 9:00 AM US ET
    Pediatric Infectious Disease for APPs 

    Workshop Speaker: Tresa Zielinski, DNP, RN, APRN-NP, CPNP-PC (she/her/hers) – Ann & Robert H. Lurie Children's Hospital of Chicago

  • 9:00 AM - 9:10 AM US ET
    BREAK 
  • 9:10 AM - 10:00 AM US ET
    Antimicrobial Management and Updates 

    Workshop Speaker: Christopher Ohl, MD – Wake Forest School of Medicine

    Workshop Speaker: Paul S. Pottinger, MD (he/him/his) – University of Washington School of Medicine

    Workshop Speaker: John C. Williamson, PharmD (he/him/his) – Wake Forest School of Medicine

  • 10:00 AM - 10:10 AM US ET
    BREAK 
  • 10:10 AM - 11:00 AM US ET
    Managing the Immunocompromised Patient

    Workshop Speaker: Denise McCulloch, MD, MPH – Fred Hutchinson Cancer Center

  • 11:00 AM - 11:10 AM US ET
    BREAK 
  • 11:10 AM - 12:00 PM US ET
    Diagnostic Stewardship 

    Workshop Speaker: Daniel J. Morgan, MD, MS – University of Maryland School of Medicine